Abstract
Suzuki-Miyaura cross-coupling of 6-bromo-2-styrylquinazolin-4(3H)-ones with arylboronic acids afforded a series of novel 6-aryl-2-styrylquinazolin-4(3H)-ones. These compounds were evaluated for potential anticancer properties against the human renal (TK-10), melanoma (UACC-62) and breast cancer (MCF-7) cell lines. Their antimicrobial properties were also evaluated against six Gram-positive and four Gram-negative bacteria, as well as two strains of fungi. Molecular docking studies (in silico) were conducted on compounds 5a, b, d and 6a, b, d-f to recognize the hypothetical binding motif of the title compounds within the active site of the dihydrofolate reductase and thymidylate synthase enzymes.
| Original language | English |
|---|---|
| Article number | 21010028 |
| Journal | Molecules |
| Volume | 21 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2016 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- 6-aryl-2- styrylquinazolin-4(3h)-ones
- 6-bromo-2-styrylquinazolin-4(3h)-ones
- Antimicrobial activity
- Docking studies
- In vitro cytotoxicity
- Suzuki-miyaura cross-coupling
ASJC Scopus subject areas
- Analytical Chemistry
- Chemistry (miscellaneous)
- Molecular Medicine
- Pharmaceutical Science
- Drug Discovery
- Physical and Theoretical Chemistry
- Organic Chemistry
Fingerprint
Dive into the research topics of 'Synthesis, biological evaluation and molecular docking studies of 6-Aryl-2-styrylquinazolin-4(3H)-ones'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver